sulfamonomethoxine has been researched along with Toxoplasmosis, Cerebral in 1 studies
Sulfamonomethoxine: Long acting sulfonamide antibacterial agent.
Toxoplasmosis, Cerebral: Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seta, N | 1 |
| Shimizu, T | 1 |
| Nawata, M | 1 |
| Wada, R | 1 |
| Mori, K | 1 |
| Sekigawa, I | 1 |
| Iida, N | 1 |
| Maeda, M | 1 |
| Hashimoto, H | 1 |
1 other study available for sulfamonomethoxine and Toxoplasmosis, Cerebral
| Article | Year |
|---|---|
A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy.
Topics: Adult; Animals; Anti-Infective Agents; Antibodies, Protozoan; Cerebral Cortex; Drug Combinations; Fe | 2002 |